China IVD market 

China’s government is investing to build up the country’s in vitro diagnostics (IVD) testing capacity and meet strong clinical demand from an ageing population. With major policies, regulations and the growth of domestic players shaking up the country’s IVD market dynamics, companies are localising and adapting their strategies to stay ahead in this fast-evolving market. Clearstate offers market data, analysis and forecasts to give you the insight needed to capture opportunities in China, the world’s largest emerging IVD market.

China IVD Hub

China IVD market updates

Clearstate’s China IVD market hub is regularly updated to share our findings on this fast-evolving market. Explore the latest in policy developments impacting the IVD products and devices market, local competition and prices.

Examine the key themes such as localisation, digitalisation, automation and novel technologies that IVD companies need to address to stay competitive.

Understand the market potential and adoption trends of IVD innovations across Chinese cities, and where and how fast domestic competition is emerging in key segments of in vitro diagnostics – core labs, molecular diagnostics, point-of-care testing, tissue diagnostics and next-generation sequencing

Discover more IVD insights and learn how IVD Gateway solutions can help prepare your business for opportunities in China’s IVD market.

Explore how Clearstate can enable your business to stay ahead in the market, inquire now.

Explore the latest China in vitro diagnostics market insights 

From market news to analysis, our articles provide concise and up-to-date information about the developments driving China IVD market growth. 

China IVD market solutions

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.